Invention Grant
- Patent Title: BASB082 Polypeptides
- Patent Title (中): BASB082多肽
-
Application No.: US09936377Application Date: 2000-03-07
-
Publication No.: US07666988B1Publication Date: 2010-02-23
- Inventor: Catherine Defrenne , Christine Delmelle , Jean-Louis Ruelle
- Applicant: Catherine Defrenne , Christine Delmelle , Jean-Louis Ruelle
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals S.A.
- Current Assignee: GlaxoSmithKline Biologicals S.A.
- Current Assignee Address: BE Rixensart
- Agency: Seed IP Group PLLC
- Priority: GB9905815.8 19990312; GB9909094.6 19990421; GB9909503.6 19990423; GB9909787.5 19990428; GB9910710.4 19990507
- International Application: PCT/EP00/01955 WO 20000307
- International Announcement: WO00/55327 WO 20000921
- Main IPC: C07K14/22
- IPC: C07K14/22 ; C07K1/00 ; C07H21/04 ; C12N1/20 ; A61K39/095 ; A61K39/02
Abstract:
The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
Information query
